STARMAP® Online: Empowering Therapeutic Development with Sparse-Data AI
November 8th 2022Learn how STARMAP® Online cultivates an advantageous outlook for customers through accessible CESS®-powered nanoparticle technology. This platform can reduce the time, cost, and risk of drug development, as well as use AI to assure data privacy and streamline decision-making for patients.
The Benefits of Tailored API Nanoparticles
November 8th 2022Learn about the benefits of tailored active pharmaceutical ingredient [API] nanoparticles in this webinar with Christopher P. Worrall, Ph.D. This presentation looks at how API nanoparticles enable patient-centric therapies and benefit many dosage forms, as well as how industry collaborations drive novel drug delivery approaches.
The Importance of the Proof-of-Concept Stage while Producing a Glioblastoma Multiform Drug Candidate
November 8th 2022Learn how TargTex partners with Nanoform to produce therapies for Glioblastoma patients. This process includes identifying novel targets with small molecules, utilizing Nanoform technology to increase the active pharmaceutical ingredient [API] concentration, and improving treatment stability to move the drug to clinical development.
The Benefits of Tailored API Nanoparticles Webinar
November 8th 2022Learn about the benefits of tailored active pharmaceutical ingredient [API] nanoparticles in this webinar with Christopher P. Worrall, Ph.D. This presentation looks at how API nanoparticles enable patient-centric therapies and benefit many dosage forms, as well as how industry collaborations drive novel drug delivery approaches.
Empowering a New Era of Patient-Centric Medicines With Nanoform Technologies
August 17th 2022Join Christian Jones, CCO of Nanoform, as he discusses what it truly means to be patient-centric in the modern pharmaceutical industry. Discover the challenges pharma companies are facing as they switch focus, as well as the actions and technologies companies are implementing to help achieve a brighter future for patients.